文献速递泌尿生殖MR

双参数MRI与多参数MRI诊断前列腺癌的头对头比较:系统综述与Meta分析

Head-to-Head Comparison Between Biparametric and Multiparametric MRI for the Diagnosis of Prostate Cancer: A Systematic Review and Meta-Analysis.
PubMed 文献 · AJR Am J Roentgenol · 2018-09-21

该系统综述与Meta分析共纳入20项研究、2142例患者,头对头比较双参数MRI(仅T2加权成像与DWI)与多参数MRI(T2加权成像、DWI、动态增强MRI)诊断前列腺癌的效能。双参数MRI汇总敏感度0.74、特异度0.90,多参数MRI汇总敏感度0.76、特异度0.89,MRI方案不是异质性的显著因素(p=0.83),多组亚组分析结果一致。

要点

  • 双参数MRI与多参数MRI诊断前列腺癌的敏感度与特异度相似。
  • 汇总敏感度:双参数MRI 0.74,多参数MRI 0.76。
  • 汇总特异度:双参数MRI 0.90,多参数MRI 0.89。

核心结论

  • 头对头比较显示,双参数MRI诊断前列腺癌的效能与多参数MRI相似,多项亚组分析结果一致。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed与Embase截至2017年11月11日,纳入20项诊断试验准确性研究、共2142例患者,以活检或根治性前列腺切除术的组织病理学结果为参考标准,采用修订版QUADAS工具评价方法学质量,敏感度与特异度采用双变量模型和分层汇总ROC(HSROC)模型汇总,并行Meta回归与多组亚组分析。

诊断标准与关键数值

  • 双参数MRI(仅T2加权成像与DWI)汇总敏感度0.74(95%CI 0.66-0.81)、汇总特异度0.90(95%CI 0.86-0.93);多参数MRI(T2加权成像、DWI、动态增强MRI)汇总敏感度0.76(95%CI 0.69-0.82)、汇总特异度0.89(95%CI 0.85-0.93);MRI方案(双参数MRI vs 多参数MRI)不是异质性的显著因素(p=0.83),在26个亚组中MRI方案均不是异质性的显著因素(p=0.25-0.97)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The purpose of this study was to perform a systematic review and meta-analysis of a head-to-head comparison between the performance of biparametric MRI (bpMRI; only T2-weighted imaging and DWI) and that of multiparametric MRI (mpMRI; T2-weighted imaging, DWI, dynamic contrast-enhanced MRI) for the diagnosis of prostate cancer.

MATERIALS AND METHODS: The PubMed and Embase databases were searched up to November 11, 2017. The search included diagnostic test accuracy studies that compared bpMRI and mpMRI for prostate cancer diagnosis with histopathologic findings from biopsy or radical prostatectomy as the reference standard. Methodologic quality was evaluated with the revised Quality Assessment of Diagnostic Accuracy Studies tool. Sensitivity and specificity were pooled by means of bivariate and hierarchic summary ROC (HSROC) modeling and graphically presented with HSROC plots. Meta-regression analysis and multiple subgroup analyses were used to compare the diagnostic performances of bpMRI and mpMRI.

RESULTS: Twenty studies (2142 patients) were included. Pooled sensitivity and specificity were 0.74 (95% CI, 0.66-0.81) and 0.90 (95% CI, 0.86-0.93) for bpMRI and 0.76 (95% CI, 0.69-0.82) and 0.89 (95% CI, 0.85-0.93) for mpMRI. MRI protocol (bpMRI vs mpMRI) was not a significant factor in heterogeneity (p = 0.83). In 26 subgroups evaluated on the basis of stratification to clinicopathologic, study, and MRI characteristics, MRI protocol (bpMRI vs mpMRI) was not a significant factor in heterogeneity in any subgroup (p = 0.25-0.97).

CONCLUSION: A head-to-head comparison showed that the performance of bpMRI was similar to that of mpMRI in the diagnosis of prostate cancer. Consistent results were found in multiple subgroup analyses.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Woo S, Suh CH, Kim SY, et al. Head-to-Head Comparison Between Biparametric and Multiparametric MRI for the Diagnosis of Prostate Cancer: A Systematic Review and Meta-Analysis. AJR Am J Roentgenol. 2018. PMID: 30240296. doi:10.2214/AJR.18.19880

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。